Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung

This study has been completed.
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00511290
First received: August 2, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
  Purpose

In the present study inflammatory mediators will be isolated in induced sputum and exhaled breath condensate and will be correlated with particulate matter measured in these samples.Particulate matter will be assessed by partcle size distribution method and shape analysis.

The aim of the study is to perform biological monitoring in environmental and occupational diseases in a non invassive fashion.


Condition Intervention
Asthma
Chronic Obstructive Pulmonary Disease
Interstitial Lung Diseases
Occupational Lung Diseases
Other: no generic names

Study Type: Observational
Study Design: Allocation: Random Sample
Primary Purpose: Screening
Time Perspective: Longitudinal

Resource links provided by NLM:


Further study details as provided by Tel-Aviv Sourasky Medical Center:

  Eligibility

Ages Eligible for Study:   7 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Ages 7-80

Exclusion Criteria:

  • FEV1 < 75% predicted pO2 < 75
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00511290

Locations
Israel
Tel-Aviv Sourasky Medical Center
Tel-Aviv, Israel, 64239
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Fireman Lizy, PhD Tel Aviv University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00511290     History of Changes
Other Study ID Numbers: TASMC-07-LF-07316-CTIL
Study First Received: August 2, 2007
Last Updated: August 2, 2007
Health Authority: Israel: Ethics Commission

Keywords provided by Tel-Aviv Sourasky Medical Center:
Primary disease or condition being studied: Asthma -COPD-Interstitial Lung Diseases-Occupational Lung Diseases

Additional relevant MeSH terms:
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Interstitial
Lung Diseases, Obstructive
Bronchial Diseases
Respiratory Tract Diseases
Immune System Diseases
Asthma
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity

ClinicalTrials.gov processed this record on July 31, 2014